1. Home
  2. COGT vs MTN Comparison

COGT vs MTN Comparison

Compare COGT & MTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cogent Biosciences Inc.

COGT

Cogent Biosciences Inc.

HOLD

Current Price

$38.44

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Logo Vail Resorts Inc.

MTN

Vail Resorts Inc.

HOLD

Current Price

$128.15

Market Cap

4.9B

ML Signal

HOLD

Company Overview

Basic Information
Metric
COGT
MTN
Founded
2014
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Services-Misc. Amusement & Recreation
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
6.0B
4.9B
IPO Year
2018
1996

Fundamental Metrics

Financial Performance
Metric
COGT
MTN
Price
$38.44
$128.15
Analyst Decision
Strong Buy
Buy
Analyst Count
15
12
Target Price
$36.21
$165.50
AVG Volume (30 Days)
1.7M
864.6K
Earning Date
05-05-2026
03-09-2026
Dividend Yield
N/A
7.16%
EPS Growth
N/A
24.05
EPS
N/A
0.65
Revenue
$7,871,000.00
$2,964,347,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1,581.80
$6.89
P/E Ratio
N/A
$191.25
Revenue Growth
N/A
2.74
52 Week Low
$3.72
$123.82
52 Week High
$43.73
$175.51

Technical Indicators

Market Signals
Indicator
COGT
MTN
Relative Strength Index (RSI) 58.37 44.17
Support Level $36.52 $126.64
Resistance Level $41.02 $145.92
Average True Range (ATR) 1.82 5.16
MACD 0.31 -0.81
Stochastic Oscillator 88.75 23.36

Price Performance

Historical Comparison
COGT
MTN

About COGT Cogent Biosciences Inc.

Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.

About MTN Vail Resorts Inc.

Vail Resorts Inc Bhd is a resorts and casinos company that operates mountain resorts and ski areas. The company has three business segments that include Mountain, Lodging, and Real Estate. The Mountain segment operates numerous ski resort properties that offer a variety of winter and summer activities, such as skiing, snowboarding, snowshoeing, hiking, and mountain biking. The Lodging segment owns and operates hotels and condominiums. The Real Estate segment owns, develops, and leases real estate, typically near its other properties. The company generates the vast majority of its revenue within the United States.

Share on Social Networks: